Clinical Trial Update: Immunization With BCG Vaccine to Prevent Tuberculosis Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Bacillus Calmette-Guérin (BCG) vaccine to prevent tuberculosis infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Tuberculosis Infection | Phase 3 | Status: TERMINATED